SoniVie receives IDE approval from FDA for its Pilot study to ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel, June 20, 2022 /PRNewswire-AsiaNet/ -- SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, announced that on May 5th 2022 the U.S. Food and Drug Administration granted IDE approva...
Authors: LATEST ASIANET NEWS RELEASES